Bioequivalence and Tolerability Assessment of a Novel Intravenous Ciclosporin Lipid Emulsion Compared to Branded Ciclosporin in Cremophor® EL

Bioequivalence and Tolerability Assessment of a Novel Intravenous Ciclosporin Lipid Emulsion Compared to Branded Ciclosporin in Cremophor® EL

Bibliographic Details
Main Authors:	Ehinger, Karl Henrik Johannes, Hansson, Magnus Joakim, Sjövall, Fredrik, Elmér, Eskil
Format:	Online
Language:	English
Published:	Springer International Publishing AG 2012
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3586182/

Similar Items

Erratum to: Bioequivalence and Tolerability Assessment of a Novel Intravenous Ciclosporin Lipid Emulsion Compared to Branded Ciclosporin in Cremophor® EL
by: Ehinger, Karl Henrik Johannes, et al.
Published: (2013)

Ciclosporin 10 years on: indications and efficacy
by: Forsythe, Peter, et al.
Published: (2014)

Ciclosporin in canine dermatology: a decade of comfort
by: DeBoer, Douglas J.
Published: (2014)

Elevation of blood ciclosporin levels by voriconazole leading to leukoencephalopathy
by: Caihong, Qu, et al.
Published: (2013)

Ciclosporin to Protect Renal function In Cardiac Surgery (CiPRICS): a study protocol for a double-blind, randomised, placebo-controlled, proof-of-concept study
by: Ederoth, Per, et al.
Published: (2016)

Endomyocardial, intralymphocyte, and whole blood concentrations of ciclosporin A in heart transplant recipients
by: Robertsen, Ida, et al.
Published: (2013)

Bioequivalence study between two formulations of ciclosporin A (Cyclavance® oral solution and Atopica® soft capsules) following a single oral administration to dogs
by: Navarro, C., et al.
Published: (2016)

Repeated oral dose tolerance in dogs treated concomitantly with ciclosporin and oclacitinib for three weeks
by: Panteri, Alessandro, et al.
Published: (2015)

Bioenergetic bypass using cell-permeable succinate, but not methylene blue, attenuates metformin-induced lactate production
by: Sarah Piel, et al.
Published: (2018-08-01)

Ciclosporin compared to prednisolone therapy for patients with pyoderma gangrenosum: cost-effectiveness analysis of the STOP GAP trial
by: Mason, J.M., et al.
Published: (2017)

Ciclosporin A Proof of Concept Study in Patients with Active, Progressive HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis
by: Martin, Fabiola, et al.
Published: (2012)

A positive serum basophil histamine release assay is a marker for ciclosporin-responsiveness in patients with chronic spontaneous urticaria
by: Iqbal, Kamran, et al.
Published: (2012)

Life-long diseases need life-long treatment: long-term safety of ciclosporin in canine atopic dermatitis
by: Nuttall, Tim, et al.
Published: (2014)

Acute Kidney Injury Due to Interaction of Methyl-1-testosterone with Ciclosporin Metabolism in a Patient with Severe Atopic Dermatitis
by: Al-Niaimi, Firas, et al.
Published: (2013)

Randomised controlled trial. Comparison Of iNfliximab and ciclosporin in STeroid Resistant Ulcerative Colitis: Trial design and protocol (CONSTRUCT)
by: Seagrove, Anne C, et al.
Published: (2014)

Nasal Planum Vasculopathy in a Scottish Terrier Dog Treated with Ciclosporin and Endonasal Stents
by: Roberta Sartori, et al.
Published: (2018-08-01)

Systematic Review and Meta-Analysis of Tacrolimus versus Ciclosporin as Primary Immunosuppression After Liver Transplant
by: Muduma, Gorden, et al.
Published: (2016)

In-vitro influence of mycophenolate mofetil (MMF) and Ciclosporin A (CsA) on cytokine induced killer (CIK) cell immunotherapy
by: Bremm, Melanie, et al.
Published: (2016)

Long-term outcome after topical ciclosporin in severe dry eye disease with a 10-year follow-up
by: Straub, Morgane, et al.
Published: (2016)

Voluntary acceptance and consumption of two oral ciclosporin formulations in dogs: two randomised, controlled studies
by: Navarro, Christelle, et al.
Published: (2015)

A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs
by: Little, Peter R, et al.
Published: (2015)

Temporal increase of platelet mitochondrial respiration is negatively associated with clinical outcome in patients with sepsis
by: Sjövall, Fredrik, et al.
Published: (2010)

Patients with sepsis exhibit increased mitochondrial respiratory capacity in peripheral blood immune cells
by: Sjövall, Fredrik, et al.
Published: (2013)

Cytokine and Nitric Oxide Levels in Patients with Sepsis – Temporal Evolvement and Relation to Platelet Mitochondrial Respiratory Function
by: Sjövall, Fredrik, et al.
Published: (2014)

Late Conversion of Kidney Transplant Recipients from Ciclosporin to Tacrolimus Improves Graft Function: Results from a Randomized Controlled Trial
by: Plischke, Max, et al.
Published: (2015)

Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial
by: Williams, John G, et al.
Published: (2016)

A Randomized Controlled Double Blind Trial of Ciclosporin versus Prednisolone in the Management of Leprosy Patients with New Type 1 Reaction, in Ethiopia
by: Lambert, Saba M., et al.
Published: (2016)

Patient and health professionals’ perspectives on the use of ciclosporin and infliximab when treating acute severe ulcerative colitis: an added dimension to the construct trial
by: Clement, Clare, et al.
Published: (2015)

Comparison of Efficacy and Safety of Ciclosporin to Prednisolone in the Treatment of Erythema Nodosum Leprosum: Two Randomised, Double Blind, Controlled Pilot Studies in Ethiopia
by: Lambert, Saba M., et al.
Published: (2016)

Retrospective case note review of chronic spontaneous urticaria outcomes and adverse effects in patients treated with omalizumab or ciclosporin in UK secondary care
by: Savic, Sinisa, et al.
Published: (2015)

Effects of Cremophor EL on distribution of Taxol to serum lipoproteins.
by: Sykes, E., et al.
Published: (1994)

The Hidden Culprit: A Case of Repeated Anaphylaxis to Cremophor
by: Kim, Young Nam, et al.
Published: (2016)

Bioequivalence of oral and intravenous carbamazepine formulations in adult patients with epilepsy
by: Tolbert, Dwain, et al.
Published: (2015)

UK Dermatology Clinical Trials Network’s STOP GAP trial (a multicentre trial of prednisolone versus ciclosporin for pyoderma gangrenosum): protocol for a randomised controlled trial
by: Craig, Fiona F, et al.
Published: (2012)

Review of Intravenous Lipid Emulsion Therapy
by: Spray, Jeffery W.
Published: (2016)

Cell-permeable succinate prodrugs bypass mitochondrial complex I deficiency
by: Ehinger, Johannes K., et al.
Published: (2016)

Sampling times and genotyping concerns in bioequivalence evaluation of branded and generic formulations
by: Zhao, Xiao-Ying, et al.
Published: (2013)

In vitro bioequivalence study of nine brands of artesunate tablets marketed in Nigeria
by: C.O. Esimone, et al.
Published: (2008-02-01)

Patients with sepsis exhibit mitochondrial biogenesis in peripheral blood immune cells
by: Sjövall, F, et al.
Published: (2012)

The polyoxyethylene castor oil Cremophor EL modifies multidrug resistance.
by: Schuurhuis, G. J., et al.
Published: (1990)